Document is current
Any future updates will be listed below
-
Authors
Kemp, Troy J.
Baisley, Kathy
Changalucha, John
Indangasi, Jackton
Whitworth, Hilary
Lacey, Charles J.
Mwanzalima, David
Hashim, Ramadhan
Kapiga, Saidi
Hayes, Richard J.
Pinto, Ligia A.
Watson-Jones, Deborah
-
Funding
Funding for this research was provided by:
UK Department of Health and Social Care
Foreign, Commonwealth and Development Office
Global Challenges Research Fund
Wellcome Trust through the Joint Global Health Trials Scheme (MR/N006135/1)
Gates Foundation (OPP1167526)
- License Information
-
More Information
Article History
Received: 15 July 2025
Accepted: 4 December 2025
First Online: 19 December 2025
Competing interests
: D.W.-J. reports a grant from GSK Biologicals in 2007 for a previous study on safety and immunogenicity of Cervarix® in Tanzania unrelated to this submitted work. K.B. reports grant support from Merck Pharmaceuticals outside the submitted work. All other authors declare no competing interests.
